We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
+$740M
Cap. Flow %
2.5%
Top 10 Hldgs %
36.41%
Holding
1,385
New
83
Increased
652
Reduced
368
Closed
52

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$163M
2
NOW icon
ServiceNow
NOW
+$139M
3
ELS icon
Equity Lifestyle Properties
ELS
+$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Top Sells

Rank Stock Value
1
KRMA
Global X Conscious Companies ETF
KRMA
+$130M
2
SUI icon
Sun Communities
SUI
+$123M
3
SBAC icon
SBA Communications
SBAC
+$108M
4
MAA icon
Mid-America Apartment Communities
MAA
+$77.2M
5
WELL icon
Welltower
WELL
+$73M

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
1151
uniQure
QURE
$2.75B
$9K ﹤0.01%
158
– –
VCYT icon
1152
Veracyte
VCYT
$4.41B
$9K ﹤0.01%
266
– –
ADPT icon
1153
Adaptive Biotechnologies
ADPT
$3.53B
$8K ﹤0.01%
530
– –
AGIO icon
1154
Agios Pharmaceuticals
AGIO
$2.09B
$8K ﹤0.01%
204
– –
ALVO icon
1155
Alvotech
ALVO
$1.2B
$8K ﹤0.01%
1,030
– –
FOLD
1156
DELISTED
Amicus Therapeutics
FOLD
$8K ﹤0.01%
986
– –
IBRX icon
1157
ImmunityBio
IBRX
$7.07B
$8K ﹤0.01%
3,173
– –
LEGN icon
1158
Legend Biotech
LEGN
$3.65B
$8K ﹤0.01%
254
-40
-14% -$1.48K
MLYS icon
1159
Mineralys Therapeutics
MLYS
$2.34B
$8K ﹤0.01%
199
-35
-15% -$757
OGS icon
1160
ONE Gas
OGS
$5.06B
$8K ﹤0.01%
95
-604
-86% -$45.2K
SUPN icon
1161
Supernus Pharmaceuticals
SUPN
$2.76B
$8K ﹤0.01%
176
-33
-16% -$1.33K
TARS icon
1162
Tarsus Pharmaceuticals
TARS
$2.54B
$8K ﹤0.01%
137
– –
XLK icon
1163
State Street Technology Select Sector SPDR ETF
XLK
$110B
$8K ﹤0.01%
58
+4
+7% +$530
GRAL
1164
GRAIL Inc
GRAL
$2.68B
$8K ﹤0.01%
129
– –
APGE icon
1165
Apogee Therapeutics
APGE
$10.1B
$7K ﹤0.01%
166
– –
ARQT icon
1166
Arcutis Biotherapeutics
ARQT
$3.5B
$7K ﹤0.01%
359
-80
-18% -$1.26K
CNTA
1167
DELISTED
Centessa Pharmaceuticals
CNTA
$7K ﹤0.01%
294
– –
DNLI icon
1168
Denali Therapeutics
DNLI
$3.78B
$7K ﹤0.01%
475
– –
ETNB
1169
DELISTED
89bio
ETNB
$7K ﹤0.01%
499
– –
EWW icon
1170
iShares MSCI Mexico ETF
EWW
$1.88B
$7K ﹤0.01%
100
-200
-67% -$12.5K
IRON icon
1171
Disc Medicine
IRON
$2.8B
$7K ﹤0.01%
113
– –
OCUL icon
1172
Ocular Therapeutix
OCUL
$1.85B
$7K ﹤0.01%
593
– –
ABCL icon
1173
AbCellera Biologics
ABCL
$1.62B
$6K ﹤0.01%
1,151
– –
ANIP icon
1174
ANI Pharmaceuticals
ANIP
$1.86B
$6K ﹤0.01%
70
– –
COGT icon
1175
Cogent Biosciences
COGT
$6.71B
$6K ﹤0.01%
416
– –
45 46
47
48 49

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2025 Portfolio in Review

As of Q3 2025, Daiwa Securities Group held 1,385 positions worth $29.6B, up 9.4% from $27.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q3 2025 filing shows 83 new, 652 increased, 368 reduced and 52 closed positions. Its largest new stake was Eagle Materials: 54,795 shares worth $12.8M. The largest sale was Global X Conscious Companies ETF, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Real Estate and Communication Services.

  • Daiwa Securities Group's largest Q3 2025 buy was Eagle Materials: 54,795 shares worth $12.8M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2025, an estimated $163M increase.
  • Daiwa Securities Group's biggest Q3 2025 reduction was Global X Conscious Companies ETF, cutting an estimated $130M.
  • Daiwa Securities Group fully exited Ansys in Q3 2025, selling an estimated $6.94M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $29.6B portfolio in Q3 2025.
  • Daiwa Securities Group opened 83 new positions and closed 52 in Q3 2025.
  • Daiwa Securities Group's portfolio value rose 9.4% quarter-over-quarter to $29.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.